Philips gives Gloucestershire Mothers more Mobility with New Cableless Fetal Monitoring Solution

Advanced cableless solution detects fetal and maternal heart rates during pregnancy, labour and delivery

August 7, 2014

Guildford, UK – Royal Philips (NYSE: PHG AEX: PHIA) today announced the UK launch of the Avalon Cableless Fetal Monitoring solution (Avalon CL), with a first installation in Gloucestershire Royal Hospital. Avalon CL’s cableless design enables mothers to move more freely during labour and uses the proprietary Smart Pulse technology to automatically detect the coincidence between maternal pulse and fetal heart rate, even for twins and triplets.


Conventional fetal monitoring solutions often present limitations for physicians and patients. Studies show that upright positions and walking are associated with a reduction in the length of the first stage of labour and women in upright positions may be less likely to have an epidural. Further to this, observational studies suggest that maintaining a supine position in labour may have adverse physiological effects on the mother and her baby1.  With Avalon CL, mothers can reap the benefits of mobility by having more flexibility to move during labour due to its cableless design and consistent monitoring ability.


Assistant Divisional Director of Midwifery at the Gloucestershire Royal Hospital, Dawn Morrall, said: “Our main aim is to deliver more choice for women in labour. We want to ensure that mothers-to-be and their babies benefit from the advantages of being mobile and upright in labour, while also providing the best possible birth experience.”


Gloucestershire Royal Hospital now has six Avalon CL units throughout the hospital’s delivery suite. The Gloucestershire team will also conduct a yearlong research project, M.U.M. (Mums Up & Mobile) which will provide invaluable insights on the benefits of making labour more mobile and help better inform decisions for women giving birth, and their babies.


Linda Woods from Philips Healthcare UK commented, “Cableless monitoring is part of the Philips focus on developmental care, which provides a holistic approach to caring for the individual mother and child across the continuum. Avalon CL also is an example of how we innovate, by deeply understanding the needs of our customers and their patients. To this end, we are excited to support the M.U.M. project, as we believe it will offer insights that will inform future innovations.”


Among its features to enhance safety and comfort for women, Avalon CL provides:

  • Coincidence detection: Avalon CL’s Smart Pulse technology allows continuous coincidence detection between the mother’s pulse and the baby’s fetal heart rate, or rates if there are multiples, without any additional transducers or cables, allowing clinicians to provide more accurate recognition and intervention.
  • Increased mobility and flexibility during labour: By removing cables, Avalon CL is more mobile and flexible, allowing women to find their most comfortable position to best manage contractions during the birth.
  • Enhanced monitoring under water: Avalon CL with Smart Pulse can be submerged under water for up to five hours for continuous monitoring, even with twins and triplets.


Avalon CL enhances the Philips Fetal and Maternal Monitors portfolio by providing advanced measurements during routine and high-risk deliveries for pregnant women.  The system transmits fetal and maternal vital signs information to a monitor via the base station. From there, patient information can be transferred seamlessly to the Philips IntelliSpace Perinatal information management system, which tracks medical information across the obstetrical care continuum – from the first antepartum visit to delivery, postpartum, newborn record, discharge and postpartum follow-up visits. For more information on Avalon Smart Pulse Technology, visit 


For more information on Philips advanced technology solutions for mother and child care, visit


1 Lawrence A, Lewis L, Hofmeyr GJ, Dowswell T, Styles C. Maternal positions and mobility during first
stage labour. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003934. DOI: 10.1002/14651858.CD003934.pub2.

Philips Avalon Gloucester Royal

Philips Avalon Gloucester Royal

Philips Avalon Gloucester Royal

For further information, please contact:

Barbara Neate 
Philips Healthcare
+ 44 (0) 1483 293 071, Mobile: + 44 (0) 7771 814 778


About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at